
-
Bobby LeBlanc Speaks to SMIF
On Tuesday, December 5th, the SMIF class had the pleasure to meet with Bucknell alumni Bobby LeBlanc. Mr. LeBlanc graduated from Bucknell in 1988. He is currently a senior managing director at Onex where he has oversight of investing activities in the Financial Services, Healthcare, Media, Technology and Telecom sectors. Prior to joining Onex, Mr.…
-
Nick Abbott Pitches AbbVie Inc. on November 20
On Wednesday, November 20, Nick Abbott pitched AbbVie Inc. (NYSE: ABBV) as an addition to our Healthcare holdings. AbbVie is a pharmaceuticals company that discovers, develops, and manufactures both biopharmaceuticals and small molecule drugs. The company originated in 2013 as a spin-off from Abbott Laboratories’ (NYSE:ABT) research-based pharmaceuticals business. AbbVie’s four primary therapeutic areas are…
-
Jeff Hagen Pitches McDonald’s on Dec. 5
On Tuesday, December 5th, Jeff Hagen, one of our Consumer Discretionary analysts, pitched McDonald’s Corporation. Jeff pointed to McDonald’s three recent growth initiatives as catalysts for future growth, including improvements in technology, a new delivery platform and menu expansions. He believes that McDonald’s is a valuable addition to the SMIF portfolio due to its commitment…